Bas Havekes

5.5k total citations · 2 hit papers
84 papers, 3.6k citations indexed

About

Bas Havekes is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Bas Havekes has authored 84 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 33 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Physiology. Recurrent topics in Bas Havekes's work include Neuroendocrine Tumor Research Advances (22 papers), Adipose Tissue and Metabolism (20 papers) and Lung Cancer Research Studies (14 papers). Bas Havekes is often cited by papers focused on Neuroendocrine Tumor Research Advances (22 papers), Adipose Tissue and Metabolism (20 papers) and Lung Cancer Research Studies (14 papers). Bas Havekes collaborates with scholars based in Netherlands, United States and Germany. Bas Havekes's co-authors include Patrick Schrauwen, Gert Schaart, Joris Hoeks, Wouter D. van Marken Lichtenbelt, Matthijs K. C. Hesselink, Vera B. Schrauwen‐Hinderling, Boudewijn Brans, Felix M. Mottaghy, Olaf M. Dekkers and Johanna A. Jörgensen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Bas Havekes

84 papers receiving 3.6k citations

Hit Papers

Short-term cold acclimation improves insulin sensitivity ... 2015 2026 2018 2022 2015 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bas Havekes Netherlands 33 1.6k 1.1k 885 659 626 84 3.6k
Masakazu Miura Japan 30 896 0.6× 651 0.6× 652 0.7× 991 1.5× 551 0.9× 85 4.0k
Renming Hu China 33 753 0.5× 532 0.5× 930 1.1× 855 1.3× 163 0.3× 105 3.1k
Blerina Kola United Kingdom 31 1.6k 1.0× 749 0.7× 2.1k 2.4× 1.1k 1.6× 248 0.4× 57 5.5k
Annayya R. Aroor United States 43 923 0.6× 800 0.7× 2.0k 2.3× 1.6k 2.5× 395 0.6× 129 5.9k
Linda Hilsted Denmark 29 531 0.3× 432 0.4× 1.3k 1.5× 770 1.2× 358 0.6× 80 3.4k
Riccardo Sarzani Italy 37 1.2k 0.8× 623 0.5× 888 1.0× 879 1.3× 140 0.2× 141 4.3k
A. Gordon Smith United States 33 1.8k 1.2× 317 0.3× 753 0.9× 398 0.6× 328 0.5× 67 3.8k
Kenneth K.Y. Cheng Hong Kong 34 1.2k 0.8× 1.2k 1.0× 260 0.3× 1.2k 1.8× 214 0.3× 86 3.4k
Takanobu Yoshimoto Japan 38 841 0.5× 449 0.4× 1.8k 2.0× 1.2k 1.8× 287 0.5× 163 4.4k
Loren E. Wold United States 29 856 0.5× 327 0.3× 274 0.3× 1.0k 1.6× 264 0.4× 74 3.3k

Countries citing papers authored by Bas Havekes

Since Specialization
Citations

This map shows the geographic impact of Bas Havekes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Havekes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Havekes more than expected).

Fields of papers citing papers by Bas Havekes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Havekes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Havekes. The network helps show where Bas Havekes may publish in the future.

Co-authorship network of co-authors of Bas Havekes

This figure shows the co-authorship network connecting the top 25 collaborators of Bas Havekes. A scholar is included among the top collaborators of Bas Havekes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas Havekes. Bas Havekes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veeraiah, Pandichelvam, Rubén Zapata‐Pérez, Esther Phielix, et al.. (2025). Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 27(5). 2864–2877. 2 indexed citations
2.
Roumans, Kay H. M., Julian Mevenkamp, Esther Kornips, et al.. (2023). A prolonged fast improves overnight substrate oxidation without modulating hepatic glycogen in adults with and without nonalcoholic fatty liver: A randomized crossover trial. Obesity. 31(3). 757–767. 2 indexed citations
3.
Bruls, Yvonne M. H., Froukje Vanweert, Ciarán E. Fealy, et al.. (2023). Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trial. Nature Communications. 14(1). 173–173. 9 indexed citations
4.
Parker, Victoria, Darren Robertson, Bas Havekes, et al.. (2023). Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes. Nature Metabolism. 5(12). 2086–2093. 35 indexed citations
6.
Fealy, Ciarán E., Kay H. M. Roumans, Niels J. Connell, et al.. (2022). Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial. Diabetologia. 65(10). 1710–1720. 67 indexed citations
7.
Gemmink, Anne, Marlies de Ligt, Esther Kornips, et al.. (2022). Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism. Molecular Metabolism. 66. 101620–101620. 28 indexed citations
8.
Ligt, Marlies de, Julian Mevenkamp, Johanna A. Jörgensen, et al.. (2022). Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial. Metabolism. 140. 155396–155396. 27 indexed citations
9.
Ligt, Marlies de, Esther Kornips, Russell Esterline, et al.. (2021). Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care. 44(6). 1334–1343. 36 indexed citations
10.
Grevendonk, Lotte, Esther Moonen‐Kornips, Johan de Vogel‐van den Bosch, et al.. (2021). NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults. Journal of Nutrition. 151(10). 2917–2931. 21 indexed citations
11.
Remie, Carlijn M. E., Kay H. M. Roumans, Emmani B. M. Nascimento, et al.. (2021). Metabolic responses to mild cold acclimation in type 2 diabetes patients. Nature Communications. 12(1). 1516–1516. 20 indexed citations
12.
Grevendonk, Lotte, Niels J. Connell, Christopher McCrum, et al.. (2021). Impact of aging and exercise on skeletal muscle mitochondrial capacity, energy metabolism, and physical function. Nature Communications. 12(1). 4773–4773. 147 indexed citations
13.
Connell, Niels J., Yvonne M. H. Bruls, Vera B. Schrauwen‐Hinderling, et al.. (2021). No evidence for brown adipose tissue activation after creatine supplementation in adult vegetarians. Nature Metabolism. 3(1). 107–117. 15 indexed citations
14.
Roumans, Kay H. M., Lucas Lindeboom, Pandichelvam Veeraiah, et al.. (2020). Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nature Communications. 11(1). 1891–1891. 85 indexed citations
15.
Laat, Joanne M. de, Rachel S. van Leeuwaarde, Annenienke C. van de Ven, et al.. (2020). The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group. The Journal of Clinical Endocrinology & Metabolism. 106(2). e1014–e1027. 16 indexed citations
16.
Leeuwaarde, Rachel S. van, Carolina R C Pieterman, Eveline M. A. Bleiker, et al.. (2018). High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group. The Journal of Clinical Endocrinology & Metabolism. 103(6). 2354–2361. 27 indexed citations
17.
Leeuwaarde, Rachel S. van, Koen M.A. Dreijerink, Margreet G.E.M. Ausems, et al.. (2017). MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group. The Journal of Clinical Endocrinology & Metabolism. 102(6). 2083–2090. 43 indexed citations
18.
Bucerius, Jan, Guy H. E. J. Vijgen, Boudewijn Brans, et al.. (2015). Impact of Bariatric Surgery on Carotid Artery Inflammation and the Metabolic Activity in Different Adipose Tissues. Medicine. 94(20). e725–e725. 24 indexed citations
19.
Laat, Joanne M. de, Olaf M. Dekkers, Carolina R C Pieterman, et al.. (2015). Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG). The Journal of Clinical Endocrinology & Metabolism. 100(9). 3288–3296. 98 indexed citations
20.
Laat, Joanne M. de, Carolina R C Pieterman, Ad R. Hermus, et al.. (2013). Low Accuracy of Tumor Markers for Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients. The Journal of Clinical Endocrinology & Metabolism. 98(10). 4143–4151. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026